Bacterial Infections  >>  Besivance (besifloxacin ophthalmic suspension)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Besivance (besifloxacin ophthalmic suspension) / Bausch Health
NCT00622908: Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis

Completed
2
270
US
ISV-403, besifloxacin, Vehicle
Bausch & Lomb Incorporated
Bacterial Conjunctivitis
06/05
06/05

Download Options